Lawrence Berkeley National Laboratory: Scientists Recruit New Atomic Heavyweights in Targeted Fight Against Cancer
December 15, 2020
December 15, 2020
WASHINGTON, Dec. 15 (TNSRes) -- The U.S. Department of Energy's Lawrence Berkeley National Laboratory issued the following news release on Dec. 14:
A promising approach to treating cancer - called targeted alpha-particle therapy or TAT - could better harness the curative power of radiation treatments and lessen the severity of their more debilitating side effects.
TAT recruits drugs containing radioactive materials called alpha-emitting radioisotopes or combined with ce . . .
A promising approach to treating cancer - called targeted alpha-particle therapy or TAT - could better harness the curative power of radiation treatments and lessen the severity of their more debilitating side effects.
TAT recruits drugs containing radioactive materials called alpha-emitting radioisotopes or combined with ce . . .